Overview
Pablo Martinez-Pena practices practicing medicine in Lund, Sweden.
Mr. Martinez-Pena is highly rated in 1 condition, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML) and Leukemia.
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pablo Martinez-Pena
Is Pablo Martinez-Pena a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Pablo Martinez-Pena is classified as an Advanced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pablo Martinez-Pena participate in research or clinical trials?
Yes. Pablo Martinez-Pena has published 14 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Pablo Martinez-Pena's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Mr. Martinez-Pena isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Experienced
- LeukemiaMr. Martinez-Pena isExperienced. Learn about Leukemia.